Venlafaxine (Page 12 of 12)

Package/Label Display Panel

Venlafaxine Tablets, USP 25mg

NDC 68001-157-00, 100 Tablets

Venlafaxine Tabs 25mg 100 Tablets -- Rev 04-17
(click image for full-size original)

Package/Label Display Panel

Venlafaxine Tablets, USP 37.5mg

NDC 68001-158-00, 100 Tablets

Venlafaxine Tabs 37.5mg 100 Tablets -- Rev 04-17
(click image for full-size original)

Package/Label Display Panel

Venlafaxine Tablets, USP 50mg

NDC 68001-159-00, 100 Tablets

Venlafaxine Tabs 50mg 100 Tablets -- Rev 04-17
(click image for full-size original)

Package/Label Display Panel

Venlafaxine Tablets, USP 75mg

NDC 68001-160-00, 100 Tablets

Venlafaxine Tabs 75mg 100 Tablets -- Rev 04-17
(click image for full-size original)

Package/Label Display Panel

Venlafaxine Tablets, USP 100mg

NDC 68001-156-00, 100 Tablets

Venlafaxine Tabs 100mg 100 Tablets -- Rev 04-17
(click image for full-size original)
VENLAFAXINE venlafaxine tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68001-157
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE) VENLAFAXINE 25 mg
Inactive Ingredients
Ingredient Name Strength
FERRIC OXIDE YELLOW
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
SODIUM STARCH GLYCOLATE TYPE A POTATO
FERRIC OXIDE RED
MICROCRYSTALLINE CELLULOSE
Product Characteristics
Color ORANGE (PEACH) Score 2 pieces
Shape ROUND (ROUND) Size 6mm
Flavor Imprint Code ZC;64
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:68001-157-00 100 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077653 11/25/2013
VENLAFAXINE venlafaxine tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68001-158
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE) VENLAFAXINE 37.5 mg
Inactive Ingredients
Ingredient Name Strength
FERRIC OXIDE YELLOW
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
SODIUM STARCH GLYCOLATE TYPE A POTATO
FERRIC OXIDE RED
MICROCRYSTALLINE CELLULOSE
Product Characteristics
Color ORANGE (PEACH) Score 2 pieces
Shape ROUND (ROUND) Size 7mm
Flavor Imprint Code ZC;65
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:68001-158-00 100 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077653 11/25/2013
VENLAFAXINE venlafaxine tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68001-159
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE) VENLAFAXINE 50 mg
Inactive Ingredients
Ingredient Name Strength
FERRIC OXIDE YELLOW
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
SODIUM STARCH GLYCOLATE TYPE A POTATO
FERRIC OXIDE RED
MICROCRYSTALLINE CELLULOSE
Product Characteristics
Color ORANGE (PEACH) Score 2 pieces
Shape ROUND (ROUND) Size 8mm
Flavor Imprint Code ZC;66
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:68001-159-00 100 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077653 11/25/2013
VENLAFAXINE venlafaxine tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68001-160
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE) VENLAFAXINE 75 mg
Inactive Ingredients
Ingredient Name Strength
FERRIC OXIDE YELLOW
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
SODIUM STARCH GLYCOLATE TYPE A POTATO
FERRIC OXIDE RED
MICROCRYSTALLINE CELLULOSE
Product Characteristics
Color ORANGE (PEACH) Score 2 pieces
Shape ROUND (ROUND) Size 10mm
Flavor Imprint Code ZC;67
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:68001-160-00 100 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077653 11/25/2013
VENLAFAXINE venlafaxine tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68001-156
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE) VENLAFAXINE 100 mg
Inactive Ingredients
Ingredient Name Strength
FERRIC OXIDE YELLOW
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
SODIUM STARCH GLYCOLATE TYPE A POTATO
FERRIC OXIDE RED
MICROCRYSTALLINE CELLULOSE
Product Characteristics
Color ORANGE (PEACH) Score 2 pieces
Shape ROUND (ROUND) Size 10mm
Flavor Imprint Code ZC;68
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:68001-156-00 100 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077653 11/25/2013
Labeler — BluePoint Laboratories (985523874)
Registrant — Zydus Pharmaceuticals (USA) Inc. (156861945)
Establishment
Name Address ID/FEI Operations
Cadila Healthcare Limited 918596198 ANALYSIS (68001-157), ANALYSIS (68001-158), ANALYSIS (68001-159), ANALYSIS (68001-160), ANALYSIS (68001-156), MANUFACTURE (68001-157), MANUFACTURE (68001-158), MANUFACTURE (68001-159), MANUFACTURE (68001-160), MANUFACTURE (68001-156)

Revised: 06/2020 BluePoint Laboratories

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2021. All Rights Reserved.